Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy

Sun, J; Shi, R; Zhang, XW; Fang, D; Rauch, J; Lu, S; Wang, XB; Kasmann, L; Ma, J; Belka, C; Su, C; Li, ML

Sun, J (corresponding author), Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Peoples R China.; Sun, J; Li, ML (corresponding author), Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Univ Hosp, Marchioninistr 15, D-81377 Munich, Germany.; Su, C (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Dept Pathogen Biol & Immunol, Jiangsu Prov Key Lab Pathogen Biol, Nanjing, Peoples R China.

ONCOIMMUNOLOGY, 2021; 10 (1):

Abstract

Although the vast majority of patients with papillary thyroid cancer (PTC) have a favorable prognosis when conventional treatments are implemented, lo......

Full Text Link